Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goodvent Beteiligungsmanagement is a German venture capital and investment management firm specializing in the life sciences, biotechnology, and nanotechnology sectors. Based in Magdeburg, the company is primarily known for managing the IBG funds (IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH), which provide risk capital to innovative high-tech startups in the Saxony-Anhalt region. Goodvent plays a critical role in the European biotech ecosystem by providing early-stage financing and strategic guidance to companies developing novel therapeutics and medical technologies. Notable portfolio companies associated with Goodvent's management include Vivoryon Therapeutics and Revotar Biopharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goodvent.